| P50 | author | Robin Fredric Anders | Q80331758 |
| P2093 | author name string | Edwards SJ | |
| | Smythe JA | |
| | Peterson MG | |
| | Franchina P | |
| | Monger C | |
| | O'Brien CM | |
| | Pye D | |
| | Vandenberg KL | |
| | Corcoran LN | |
| P2860 | cites work | Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase | Q27860571 |
| | Identification of two integral membrane proteins of Plasmodium falciparum | Q30039245 |
| | A cDNA clone expressing a rhoptry protein of Plasmodium falciparum | Q30039628 |
| | T-cell epitopes in Pf155/RESA, a major candidate for a Plasmodium falciparum malaria vaccine | Q33636558 |
| | Immunization with a Plasmodium falciparum merozoite surface antigen induces a partial immunity in monkeys | Q34628596 |
| | Structure of the RESA gene of Plasmodium falciparum. | Q35055418 |
| | Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. | Q36245488 |
| | Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum | Q36348872 |
| | Expression of the RESA gene in Plasmodium falciparum isolate FCR3 is prevented by a subtelomeric deletion | Q36759610 |
| | Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity | Q36896352 |
| | General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. | Q36913229 |
| | Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin | Q37347836 |
| | Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters | Q37508631 |
| | Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus | Q43756145 |
| | Live recombinant vaccinia virus protects chimpanzees against hepatitis B. | Q45795610 |
| | Variation in the precursor to the major merozoite surface antigens of Plasmodium falciparum | Q46869643 |
| | Immunization of Aotus monkeys with recombinant proteins of an erythrocyte surface antigen of Plasmodium falciparum | Q47887195 |
| | Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia | Q47897648 |
| | Immune sera recognize on erythrocytes Plasmodium falciparum antigen composed of repeated amino acid sequences | Q47979862 |
| | Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum | Q48273602 |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | malaria | Q12156 |
| | Plasmodium falciparum | Q311383 |
| P304 | page(s) | 2403-2411 | |
| P577 | publication date | 1991-07-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria | |
| P478 | volume | 59 | |